Affordable Access

deepdyve-link
Publisher Website

Etiology of Microcephaly and Central Nervous System Defects during the Zika Epidemic in Colombia

Authors
  • Galang, Romeo R.1
  • Avila, Greace Alejandra2
  • Valencia, Diana1
  • Daza, Marcela3
  • Tong, Van T.1
  • Bermúdez, Antonio José4
  • Gilboa, Suzanne M.1
  • Rico, Angélica4
  • Cates, Jordan1
  • Pacheco, Oscar2
  • Winfield, Christina M.1
  • Prieto, Franklyn2
  • Honein, Margaret A.1
  • Cortés, Liliana J.2
  • Moore, Cynthia A.1
  • Ospina, Martha L.5
  • 1 Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, United States;
  • 2 Dirección de Vigilancia y Análisis de Riesgo en Salud Pública, Instituto Nacional de Salud, Bogotá, Distrito Capital, Colombia;
  • 3 Vysnova Partners, Research Division, Bethesda, MD, United States;
  • 4 Dirección de Redes en Salud Pública; Bogotá, Distrito Capital, Colombia
  • 5 Dirección General, Instituto Nacional de Salud, Bogotá, Distrito Capital, Colombia
Type
Published Article
Journal
The Journal of pediatrics
Publication Date
May 13, 2020
Volume
222
Pages
112–119
Identifiers
DOI: 10.1016/j.jpeds.2020.02.023
PMID: 32417080
PMCID: PMC7321917
Source
PubMed Central
License
Unknown

Abstract

Objective To estimate the prevalence of microcephaly and central nervous system (CNS) defects during the Zika virus (ZIKV) epidemic in Colombia and proportion attributable to congenital ZIKV infection. Study design Clinical and laboratory data for cases of microcephaly and/or CNS defects reported to national surveillance between 2015 and 2017 were reviewed and classified by a panel of clinical subject matter experts. Maternal and fetal/infant biologic specimens were tested for congenital infection and chromosomal abnormalities. Infants/fetuses with microcephaly and/or CNS defects (cases) were classified into broad etiologic categories (teratogenic, genetic, multifactorial, and unknown). Cases classified as potentially attributable to congenital ZIKV infection were stratified by strength of evidence for ZIKV etiology (strong, moderate, or limited) using a novel strategy considering birth defects unique or specific to ZIKV or other infections and laboratory evidence. Results Among 858 reported cases with sufficient information supporting a diagnosis of microcephaly or CNS defects, 503 were classified as potentially attributable to congenital ZIKV infection. Of these, the strength of evidence was considered strong in 124 (24.7%) cases; moderate in 232 (46.1%) cases; and limited in 147 (29.2%). Of the remaining, 355 (41.4%) were attributed to etiologies other than ZIKV infection (syphilis, toxoplasmosis, rubella, cytomegalovirus, herpes 1 and herpes 2 viruses only, n = 32 [3.7%]; genetic, n = 16 [1.9%]; multifactorial, n = 42 [4.9%]; unknown, n = 265 [30.9%]). Conclusions Fifty-eight percent of cases of microcephaly and/or CNS defects were potentially attributable to congenital ZIKV infection; however, the strength of evidence varied considerably. This surveillance protocol might serve as a model approach for investigation and etiologic classification of complex congenital conditions.

Report this publication

Statistics

Seen <100 times